ZTS | Zoetis
161.49 -5.00 (-3.00%)
ZTS Price Profile
Open
$164.12
CLOSE
$161.49
DAY RANGE
161.42 - 165.18
52 WEEK RANGE
156.67 - 249.27
MARKET CAP
89.82B
Trading volume
1.61M
Prev. Close
166.49
50 Day MA
223.36
Shares Outstanding
473.13M
Public Float
472.41M
Average Volume
2.84M
Beta
0.66
PEG Ratio
3.27
Shares Shorted
2.02M
% OF SHARES SHORTED
0.43%
Short Ratio
1.35
1 Year Performance
24.74%
Diluted EPS (TTM)
4.15
Q Revenue Growth
0.11
Ebitda
3.14B
Gross Profit (TTM)
4.64B
Total Cash (MRQ)
3.3B
Total Debt (MRQ)
6.76B
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Zoetis (ZTS) company profile
Zoetis Inc. (NYSE: ZTS) is an American company that discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products with customers globally. The company also offers pharmaceutical products, including pain and sedation, antiemetic, reproductive, and oncology products. The company’s business focuses on commercializing products across eight key species: dogs, cats, horses, cattle, swine, poultry, fish, and sheep.
